# Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

> **NCT00703976** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 80 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Cetuximab
- **DRUG:** Pemetrexed
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT00703976
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703976, "Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00703976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*